We used the myoma model in conjunction with gene expression profiling with microarray data as an efficient tool for high throughput analysis and to screen for differentially expressed genes. Our aim w
(A) To determine the statistical significance of selected genes, we counted the number of genes identified in each step of our analysis. (B) Utilizing a set of 93 genes that are implicated in GBMs as
